November 2020

Column

Editor's Page

11/18/2020

Winston Wong, PharmD, Editor-in-Chief

Disease, clinical research, pathology, drugs, treatment guidelines and protocols, diagnostic tests and procedure, regulations, reimbursement—these are everyday elements of the average physician, and they are...

...

11/18/2020

Journal of Clinical Pathways

Trending From ACCC

Implementing “Many Layers of Change”

11/18/2020

Association of Community Cancer Centers

Although change is inherent in oncology, the COVID-19 pandemic has raised the bar. As the calendar year draws to a close, the Association of Community Cancer Centers (ACCC) is leaning in to change. With membership,...

...

11/18/2020

Journal of Clinical Pathways

Engaging Payers

An Alternative Value-Based Care Model for Chronic Conditions

11/18/2020

Lili Brillstein, MPH—Column Editor

Chronic diseases represent a growing burden of morbidity, mortality, and cost worldwide. Individuals requiring chronic care are most vulnerable to the type of care delivered under the fee-for-service (FFS) model,...

...

11/18/2020

Journal of Clinical Pathways

Department

Pathways in Practice

Managing Cost, Patient Factors in a Multiple Myeloma Pathway

11/18/2020

JCP Editors

In this journal section, we speak with cancer care practitioners about their clinical pathways and the pathways programs being used in their practice, how they are being applied in a particular disease state, and...

In...

11/18/2020

Journal of Clinical Pathways

Pathways Award

The Journal of Clinical Pathways’ Excellence in Pathways Award Winners Announced at OCPC 2020

11/18/2020

JCP Editors

Throughout the year, editorial staff and board members at Journal of Clinical Pathways (JCP) collaborate with countless oncologists and cancer care professionals in the field. Through their relationships with...

...

11/18/2020

Journal of Clinical Pathways

Clinical Pathways Forum

EMR Integration of Moffitt Cancer Center Clinical Pathways

11/18/2020

Mishellene McKinney, MHA, RN, OCN—Column Editor

Founded in 2016, the Clinical Pathways Forum is a community of pathways professionals—now totaling 15 institutions from across the United States—who are utilizing clinical pathways in their practices and institutions...

...

11/18/2020

Journal of Clinical Pathways

Feature

From the Field

Update on the Evolution of The US Oncology Network’s Clinical Pathways Program

11/18/2020

Aimee Ginsburg, PharmD, BCPS

Marcus Neubauer, MD

Lalan Wilfong, MD

Abstract: The National Comprehensive Cancer Network (NCCN) Guidelines are seen as the most comprehensive and most frequently updated cancer clinical practice guidelines available. Clinical pathways have a narrower...

...

11/18/2020

Journal of Clinical Pathways

Perspectives

Approaching Clinical Pathway Development as an Art

11/18/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD

Craig Ornstein, PhD

Seth Gordon, MBA

Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders—clinically and...

...

11/18/2020

Journal of Clinical Pathways

Current Issue

August 2024

Volume 10

Issue 4

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

November 2020

Column

Department

Feature

Current Issue

Special Reports

Subscribe

Volume 6

Specialties

Events

Year Round Education

HMP Global Products